Haemophagocytic Lymphohistiocytosis — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — EBV-associated haemophagocytic lymphohistiocytosis (HLH)
Immunosuppressed patients on azathioprine (particularly those with IBD who are EBV-seronegative at the time of starting immunosuppression) are at risk of EBV-triggered HLH. HLH presents with fever, pancytopaenia, hyperferritinaemia (often >10,000 µg/L), hypertriglyceridaemia, hepatosplenomegaly, and elevated soluble IL-2 receptor. Bone marrow may show haemophagocytosis. H-Score aids diagnosis. Treatment includes etoposide-based protocols and cessation of immunosuppression.
Reference: eTG – 2025 – Haematology; Histiocyte Society – 2004 – HLH-2004 Protocol